The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Curis
Stock and Other Ownership Interests - Curis
 
Research Funding - Abbvie; Oxford Gene Technology
Travel, Accommodations, Expenses - Abbvie; Oxford Gene Technology
Predictive biomarkers of response to the IRAK4/FLT3 inhibitor emavusertib in hematological malignancies.
 
Klaus H Metzeler
No Relationships to Disclose
 
Uwe Platzbecker
Honoraria - Abbvie; Celgene/Jazz; Curis; Geron; Janssen
Consulting or Advisory Role - BMS GmbH & Co. KG; Celgene/Jazz; Novartis
Research Funding - Amgen (Inst); BerGenBio (Inst); Celgene (Inst); Curis (Inst); Janssen (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - part of a patent for a TFR-2 antibody (Rauner et al. Nature Metabolics 2019)
Travel, Accommodations, Expenses - Celgene
 
Eric S. Winer
Consulting or Advisory Role - Curis; Jazz Pharmaceuticals
 
Amit Verma
Leadership - Novasenta
Stock and Other Ownership Interests - Stelexis Therapeutics
Consulting or Advisory Role - Bristol-Myers Squibb; Curis
Research Funding - Bristol-Myers Squibb; Celgene; Curis; GlaxoSmithKline; Incyte; Janssen; MedPacto; Prelude Therapeutics
 
Daniel J. DeAngelo
Consulting or Advisory Role - Amgen; Blueprint Medicines; Gilead Sciences; Incyte; Jazz Pharmaceuticals; Novartis; Pfizer; servier; takeda
Research Funding - Abbvie (Inst); Blueprint Medicines (Inst); glycomimetics (Inst); Novartis (Inst)
 
Mariano Severgnini
Employment - Curis
Stock and Other Ownership Interests - Curis
Patents, Royalties, Other Intellectual Property - Curis
 
Gaurav S Choudhary
Employment - Curis
Stock and Other Ownership Interests - Curis
 
Wanying Zhao
Employment - Curis; Merck (I)
Stock and Other Ownership Interests - Curis; Incyte
 
Maureen E Lane
Employment - Curis
Leadership - Curis
Stock and Other Ownership Interests - Curis
Patents, Royalties, Other Intellectual Property - Curis
 
Cole Gallagher
Employment - Curis
Stock and Other Ownership Interests - Curis
 
Dora Ferrari
No Relationships to Disclose
 
Alyssa Masciarelli
Employment - Curis
Stock and Other Ownership Interests - Curis
Patents, Royalties, Other Intellectual Property - Curis
 
Reinhard W. Von Roemeling
Employment - Curis
Leadership - Curis
Stock and Other Ownership Interests - Curis
 
Samantha Carlisle
Employment - Monoceros Biosystems
 
David Nickle
Employment - Monoceros Biosystems
Patents, Royalties, Other Intellectual Property - Gossamer Bio; Merck
 
Guillermo Garcia-Manero
Honoraria - Abbvie; Acceleron Pharma; Astex Pharmaceuticals; Bristol-Myers Squibb/Celgene; Curis; Genentech; Gilead Sciences; Novartis
Consulting or Advisory Role - Acceleron Pharma; Astex Pharmaceuticals; Bristol-Myers Squibb
Research Funding - Abbvie; Aprea Therapeutics; Astex Pharmaceuticals; Bristol-Myers Squibb; Curis; Genentech; Gilead Sciences; Novartis